Novartis to Present Key Prostate and Breast Cancer Data at ESMO
BASEL, Switzerland, Sept. 26, 2025 — Novartis announced it will present 34 abstracts from its oncology pipeline at the...
Breast Cancer
Advertisement
Phase III Study Shows Giredestrant Boosts Breast Cancer Survival
Basel, Switzerland — September 22, 2025 — Positive phase III trial results from the evERA study reveal that the...
Atossa Pursues FDA Path for Low-Dose (Z)-Endoxifen in Breast Cancer Prevention
Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company, announced it has filed a request for a Type C...
Advertisement
